Agenus Inc (AGEN) – Company Profile and SWOT Analysis
- Pages: 57
- Published: March 2026
- Report Code: MLPH4419FSA
Agenus Inc (AGEN) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Key Highlights
Agenus Inc (Agenus) is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. The company is advancing therapies targeting cancer through a pipeline of immunological agents. Its portfolio includes several advanced platforms and programs designed to drive innovation in immuno-oncology (I-O). These consist of multiple proprietary antibody discovery platforms; antibody candidate programs such as botensilimab and balstilimab; a saponin-based vaccine adjuvant platform centered around the STIMULON cultured plant cell (CPC) QS-21 adjuvant and a pipeline of novel allogeneic invariant natural killer T (iNKT) cell therapies for treating cancer and other immune-mediated diseases. The company's products are primarily used by healthcare providers to treat various cancers, including colorectal and melanoma. Agenus is headquartered in Lexington, Massachusetts, the US.
Scope
• Detailed information on Agenus Inc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Agenus Inc in the form of a SWOT analysis
• An in-depth view of the business model of Agenus Inc including a breakdown and examination of key business segments
• News about Agenus Inc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Agenus Inc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Agenus Inc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Agenus Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Regeneron Pharmaceuticals Inc
Boehringer Ingelheim International GmbH
Arcus Biosciences Inc
Innovent Biologics Inc
Genentech Inc
Johnson & Johnson Innovative Medicine
Janssen Pharmaceuticals Inc
CStone Pharmaceuticals Co Ltd
AbbVie Inc
Harbin Gloria Pharmaceuticals Co Ltd
Beigene USA Inc
AstraZeneca Plc
Sanofi
Jiangsu Hengrui Pharmaceuticals Co Ltd
Incyte Corp
Gilead Sciences Inc
Checkpoint Therapeutics Inc
3D Medicines Inc
MabSpace Biosciences (Suzhou) Co Ltd
Jiangsu Alphamab Biopharmaceuticals Co Ltd
ImmuneOncia Therapeutics Inc
GSK plc
Bristol-Myers Squibb Co
Akeso Biopharma, Inc.
Qilu Pharmaceutical Co Ltd
Pfizer Inc
Merck & Co Inc
Harbour BioMed (Guangzhou) Co Ltd
Dynavax Technologies Corp
Amgen Inc
Ono Pharmaceutical Co Ltd
Lepu Biopharma Co Ltd
Jacobio Pharmaceuticals Group Co Ltd
Genor BioPharma Co Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.